2017 Japan Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing: Country Segment Forecasts, Emerging Technologies, Competitive Strategies
Complete report $2,450. DataPack (test volumes, sales forecasts, supplier shares) $1,450.
The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget.
This new study from VPGMarketResearchcontains 410 pages, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next five years.
Report Highlights
Genetic Diseases, Cancer, Forensic and Paternity molecular diagnostic testing markets are among the most rapidly growing segments of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by these markets, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.
Japan Market Overview
Extensive strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D.
Opportunities and Strategic Recommendations
The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget.
This new study from VPGMarketResearchcontains 410 pages, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next five years.
Report Highlights
- Market shares of leading suppliers
- Business and technological trends in major markets
- Five-year test volume and sales forecasts
- Market shares of leading competitors
- Feature comparison of major analyzers
- Strategic profiles of leading market players and start-up firms developing innovative products
- Specific product and business opportunities for instrument and consumable suppliers.
Genetic Diseases, Cancer, Forensic and Paternity molecular diagnostic testing markets are among the most rapidly growing segments of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by these markets, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.
Japan Market Overview
- Laboratories performing DNA sequencing and molecular diagnostic testingby country and market segment.
- Five-year test volume and sales projections.
- Five-year test volume and sales projections:
- Infectious Diseases - Forensic Testing-Cancer - Paternity Testing/HLA Typing- Genetic Diseases - Others
- A comprehensive analysis of the sequencing market by laboratory segment.
- Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers.
- Comparison of the major molecular diagnosticanalyzers.
- Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over target/signal amplification methods.
- Worldwide listings of companies, universities and research centers developing new molecular diagnostictechnologies and products.
Extensive strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D.
- Abbott
- Affymetrix
- Agilent Technologies
- Applied Gene Technologies
- Arca Biopharma
- Beckman Coulter/Danaher
- Becton Dickinson
- Biokit
- BioMerieux
- Bio-Rad
- Biotest
- CellMark Forensics/LabCorp
- Cepheid
- Decode Genetics
- Diadexus
- Eiken
- Elitech Group
- Enzo
- Exact Sciences
- Fujirebio
- Grifols
- Hologic/Gen-Probe
- Illumina
- Kreatech/Leica
- Li-Cor Biosciences
- Monogram Biosciences
- Myriad Genetics
- Ortho-Clinical Diagnostics
- Perkin Elmer/Caliper
- Proteome Sciences
- Qiagen
- Roche
- Scienion
- Sequenom
- Shimadzu
- Siemens
- Sierra Molecular
- Takara Bio
- Tecan Group
- Thermo Fisher
Opportunities and Strategic Recommendations
- Specific new product development opportunities with potentially significant market appeal during the next five years.
- Design criteria for new products.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.
- Business planning issues and concerns.
INTRODUCTION
GLOBAL MARKET TRENDS AND EMERGING TECHNOLOGIES
A. DNA Sequencing
B. DNA and RNA Probe Technology
C. Detection Technologies
D. Instrumentation: Review of Automated and Semi-Automated Analyzers
E. Biochips: Genosensors, Microarrays, Labs-on-the-Chip
F. Pharmacogenomics
G. Cancer Molecular Diagnostics Testing
1. Overview
2. Major Cancer Types
3. Oncogenes
H. Genetic Diseases Molecular Diagnostic Testing
1. Overview
2. Nucleic Acid Amplification
3. Chromosome Imaging
4. Genomics Technologies
5. Proteomics Technologies
6. Current Pharmacogenomic Testing
7. Major Diseases
I. Forensic Molecular Diagnostics Testing
1. Overview
2. Multilocus and Single Locus Probes
3. The FBI
4. DNA Profile Data Banks
5. Judicial Implementation
6. Major Crime Categories
7. Factors Contributing to the DNA Probe Major Expansion
J. Paternity Testing/HLA Typing Molecular Diagnostic Testing
K. Other Molecular Diagnostic Testing Applications
L. Competing/Complementing Technologies
JAPAN
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
Volume Forecasts by Market Segment
Sales Forecasts by Market Segment
Major Supplier Sales and Market Shares
MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES
A. Opportunities for New Instrumentation
B. Opportunities for New Reagent Kits and Test Systems/Panels
C. Opportunities for New IT, Computers, Software and Automation
D. Opportunities for New Auxiliary Products
DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS
ALTERNATIVE MARKET PENETRATION STRATEGIES
POTENTIAL MARKET ENTRY BARRIERS AND RISKS
COMPETITIVE PROFILES
Abbott
Affymetrix
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biokit
BioMerieux
Bio-Rad
Biotest
Cepheid
CellMark Forensics/LabCorp
Decode Genetics
Diadexus
Eiken
Elitech Group
Enzo
Exact Sciences
Fujirebio
Grifols
Hologic/Gen-Probe
Illumina
Kreatech/Leica
Li-Cor Biosciences
Monogram Biosciences
Myriad Genetics
Ortho-Clinical Diagnostics
Perkin Elmer/Caliper
Proteome Sciences
Qiagen
Roche
Scienion
Sequenom
Shimadzu
Siemens
Sierra Molecular
Takara Bio
Tecan Group
Thermo Fisher
APPENDIXES
GLOBAL MARKET TRENDS AND EMERGING TECHNOLOGIES
A. DNA Sequencing
B. DNA and RNA Probe Technology
C. Detection Technologies
D. Instrumentation: Review of Automated and Semi-Automated Analyzers
E. Biochips: Genosensors, Microarrays, Labs-on-the-Chip
F. Pharmacogenomics
G. Cancer Molecular Diagnostics Testing
1. Overview
2. Major Cancer Types
3. Oncogenes
H. Genetic Diseases Molecular Diagnostic Testing
1. Overview
2. Nucleic Acid Amplification
3. Chromosome Imaging
4. Genomics Technologies
5. Proteomics Technologies
6. Current Pharmacogenomic Testing
7. Major Diseases
I. Forensic Molecular Diagnostics Testing
1. Overview
2. Multilocus and Single Locus Probes
3. The FBI
4. DNA Profile Data Banks
5. Judicial Implementation
6. Major Crime Categories
7. Factors Contributing to the DNA Probe Major Expansion
J. Paternity Testing/HLA Typing Molecular Diagnostic Testing
K. Other Molecular Diagnostic Testing Applications
L. Competing/Complementing Technologies
JAPAN
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
Volume Forecasts by Market Segment
Sales Forecasts by Market Segment
Major Supplier Sales and Market Shares
MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES
A. Opportunities for New Instrumentation
B. Opportunities for New Reagent Kits and Test Systems/Panels
C. Opportunities for New IT, Computers, Software and Automation
D. Opportunities for New Auxiliary Products
DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS
ALTERNATIVE MARKET PENETRATION STRATEGIES
POTENTIAL MARKET ENTRY BARRIERS AND RISKS
COMPETITIVE PROFILES
Abbott
Affymetrix
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biokit
BioMerieux
Bio-Rad
Biotest
Cepheid
CellMark Forensics/LabCorp
Decode Genetics
Diadexus
Eiken
Elitech Group
Enzo
Exact Sciences
Fujirebio
Grifols
Hologic/Gen-Probe
Illumina
Kreatech/Leica
Li-Cor Biosciences
Monogram Biosciences
Myriad Genetics
Ortho-Clinical Diagnostics
Perkin Elmer/Caliper
Proteome Sciences
Qiagen
Roche
Scienion
Sequenom
Shimadzu
Siemens
Sierra Molecular
Takara Bio
Tecan Group
Thermo Fisher
APPENDIXES
LIST OF TABLES
Oncogenes Potential Applications in Cancer Diagnosis
Major Companies Developing or Marketing Cancer Molecular Diagnostic Tests
Major Companies Developing or Marketing Molecular Diagnostic Tests For Genetic Diseases
Japan, Laboratories Performing DNA Sequencing by Market Segment
Japan, Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
Japan, Molecular Diagnostic Test Volume Forecast By Major Application
Japan, Molecular Diagnostic Market Forecast By Major Application
Japan, Molecular Diagnostics Market By Major Supplier
Oncogenes Potential Applications in Cancer Diagnosis
Major Companies Developing or Marketing Cancer Molecular Diagnostic Tests
Major Companies Developing or Marketing Molecular Diagnostic Tests For Genetic Diseases
Japan, Laboratories Performing DNA Sequencing by Market Segment
Japan, Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
Japan, Molecular Diagnostic Test Volume Forecast By Major Application
Japan, Molecular Diagnostic Market Forecast By Major Application
Japan, Molecular Diagnostics Market By Major Supplier
